Company Filing History:
Years Active: 2025
Title: Hui-Fang Chang: Innovator in Pharmaceutical Chemistry
Introduction
Hui-Fang Chang is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical pathways in various diseases.
Latest Patents
Hui-Fang Chang holds a patent for "Substituted indazoles as IRAK4 inhibitors." This patent relates to chemical compounds of Formula (A) and their pharmaceutically acceptable salts. These compounds are designed to inhibit IRAK4 and can be utilized in the treatment of respiratory diseases, cancer, inflammatory diseases, and autoinflammatory or autoimmune diseases.
Career Highlights
Chang is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work focuses on innovative solutions that address unmet medical needs through advanced research and development.
Collaborations
Hui-Fang Chang collaborates with various professionals in his field, including his coworker Stefan Schiesser. Their combined expertise contributes to the advancement of pharmaceutical research and the development of new therapeutic options.
Conclusion
Hui-Fang Chang's work exemplifies the impact of innovative research in the pharmaceutical industry. His contributions to the development of IRAK4 inhibitors highlight the potential for new treatments in various diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.